Common Stock, Shares, Outstanding of Celldex Therapeutics, Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Celldex Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Celldex Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 66,549,442, a 0.26% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Celldex Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 66,549,442 +174,893 +0.26% 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 66,446,846 +102,610 +0.16% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 66,394,241 +113,574 +0.17% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 66,384,191 +473,643 +0.72% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 66,374,549 +10,491,172 +19% 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 66,344,236 +19,080,039 +40% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 66,280,667 +19,026,854 +40% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 65,910,548 +18,665,867 +40% 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 55,883,377 +8,682,682 +18% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 47,264,197 +168,134 +0.36% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 47,253,813 +489,110 +1% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 47,244,681 +490,333 +1% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 47,200,695 +470,497 +1% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q3 2022 47,096,063 +432,723 +0.93% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 46,764,703 +7,148,007 +18% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 46,754,348 +7,139,710 +18% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 46,730,198 +7,126,427 +18% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 46,663,340 +7,100,868 +18% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 39,616,696 +522,828 +1.3% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 39,614,638 +21,883,836 +123% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 39,603,771 +22,631,694 +133% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 39,562,472 +23,657,952 +149% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 39,093,868 +24,276,951 +164% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 17,730,802 +4,886,091 +38% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 16,972,077 +5,014,442 +42% 31 Dec 2019 10-K 29 Mar 2021 2020 FY
Q3 2019 15,904,520 -152,670,984 -91% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 14,816,917 -141,828,946 -91% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 12,844,711 -130,524,073 -91% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 11,957,635 +2,722,942 +29% 31 Dec 2018 10-K 26 Mar 2020 2019 FY
Q3 2018 168,575,504 +36,467,026 +28% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 156,645,863 +29,233,888 +23% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 143,368,784 +19,195,055 +15% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 9,234,693 -111,281,961 -92% 31 Dec 2017 10-K 07 Mar 2019 2018 FY
Q3 2017 132,108,478 +30,859,657 +30% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 127,411,975 +28,017,438 +28% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 124,173,729 +25,455,245 +26% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 120,516,654 +21,831,059 +22% 31 Dec 2016 10-K 07 Mar 2018 2017 FY
Q3 2016 101,248,821 +2,603,129 +2.6% 30 Sep 2016 10-Q 07 Nov 2016 2016 Q3
Q2 2016 99,394,537 +846,218 +0.86% 30 Jun 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 98,718,484 +237,852 +0.24% 31 Mar 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 98,685,595 +9,092,816 +10% 31 Dec 2015 10-K 14 Mar 2017 2016 FY
Q3 2015 98,645,692 +9,208,759 +10% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 98,548,319 +9,152,159 +10% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 98,480,632 +9,122,789 +10% 31 Mar 2015 10-Q 29 Apr 2015 2015 Q1
Q4 2014 89,592,779 +345,947 +0.39% 31 Dec 2014 10-K/A 25 Feb 2016 2015 FY
Q3 2014 89,436,933 +8,328,824 +10% 30 Sep 2014 10-Q 05 Nov 2014 2014 Q3
Q2 2014 89,396,160 +8,418,464 +10% 30 Jun 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 89,357,843 +8,487,523 +10% 31 Mar 2014 10-Q 01 May 2014 2014 Q1
Q4 2013 89,246,832 +24,887,319 +39% 31 Dec 2013 10-K 24 Feb 2015 2014 FY
Q3 2013 81,108,109 +20,300,759 +33% 30 Sep 2013 10-Q 08 Nov 2013 2013 Q3
Q2 2013 80,977,696 +22,224,125 +38% 30 Jun 2013 10-Q 06 Aug 2013 2013 Q2
Q1 2013 80,870,320 +22,134,684 +38% 31 Mar 2013 10-Q 03 May 2013 2013 Q1
Q4 2012 64,359,513 +20,148,877 +46% 31 Dec 2012 10-K 03 Mar 2014 2013 FY
Q3 2012 60,807,350 +16,660,136 +38% 30 Sep 2012 10-Q 02 Nov 2012 2012 Q3
Q2 2012 58,753,571 +14,606,357 +33% 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 58,735,636 31 Mar 2012 10-Q 04 May 2012 2012 Q1
Q4 2011 44,210,636 +12,155,254 +38% 31 Dec 2011 10-K 08 Mar 2013 2012 FY
Q3 2011 44,147,214 30 Sep 2011 10-Q 03 Nov 2011 2011 Q3
Q2 2011 44,147,214 30 Jun 2011 10-Q 04 Aug 2011 2011 Q2
Q4 2010 32,055,382 31 Dec 2010 10-K 08 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.